Individuals living with Geographic Atrophy (G.A.) or age-related macular degeneration (A.M.D) are invited to share their experiences as part of a Patient Advisory Council supported by a pharmaceutical company. The council will bring together a group of adults over the age of 50 and diagnosed with G.A to participate in virtual discussions about their patient journey [Read More]
News
Share Your Story About Step Therapy
The Prevent Blindness government affairs team has been notified of a potential opportunity to share your story with lawmakers about the harmful impact of “step therapy.” We understand that, in an effort to pass the Safe Step Act into law, legislators want to hear patient stories that will help compel action on this important bill. [Read More]
Join a Paid wAMD or DME Research Study
Exafield US, a healthcare market research recruiting company, is conducting an important study to better understand the real-life experiences of individuals living with wet Age-Related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) ELIGIBILITY Must be diagnosed with wAMD or DME Must have had at least 1 eye injection treatment STUDY HIGHLIGHTS: Format: one 60-minute [Read More]
FDA Approves Updated Vabysmo Label To Extend Treatment For Macular Edema Following Retinal Vein Occlusion (Rvo) Beyond Six Months
Genentech has received FDA approval of Vabysmo® for the treatment of macular edema due to retinal vein occlusion (RVO) beyond six months. RVO affects over a million Americans and often involves long-term intravitreal therapy to address the chronic nature of the disease. “This label update reinforces our commitment to delivering consistent, long-term solutions for patients [Read More]
PRIMA System Improves Sight in Individuals With Geographic Atrophy
A study involving participants with geographic atrophy due to dry AMD, has shown that a photovoltaic subretinal implant, combined with glasses that project near-infrared light to the implant, has led to significant improvement in visual acuity in 32 participants. This so-called PRIMA system represents the first eye prosthesis to restore functional sight in people with [Read More]